The 15.08x forward P/E versus a 21.48x trailing P/E implies roughly 42% expected EPS expansion, which appears inconsistent with the 2.3% year-over-year revenue growth most recently flagged; the more plausible interpretation is a depressed trailing base distorted by the non-operating swings already identified in quarterly EPS growth of -58.7% to +137%. The 8.61x price-to-book against a 5.0% ROIC versus Mondelez's 3.04x book and 6.0% ROIC suggests the market is capitalizing brand intangibles and unconsolidated replacement value rather than current returns on capital, a premium that warrants validation through volume recovery. Meanwhile, the 12.27x EV/EBITDA discount to Coca-Cola's 27.87x may simply reflect the higher capital intensity of PepsiCo's owned distribution fleet rather than a valuation anomaly.

Gross margin has held in a narrow 52.6-55.9% band across ten quarters, indicating pricing has largely kept pace with commodity inflation, but operating margin has swung from 8.1% in 2024Q4 to 18.0% in 2024Q2, so the mid-cycle figure nearer 15-16% is the more defensible underwriting assumption. Net margin of 12.1% versus Coca-Cola's 27.3% appears structural rather than cyclical, a consequence of consolidating bottling and snack manufacturing rather than a licensing model. Because SG&A has grown roughly 12% against 9.5% gross profit growth, incremental revenue is currently converting below average, meaning reported margin improvement should be treated as recovery from the 2024 trough rather than evidence of durable operating leverage.

ROIC has oscillated between 3.0% and 5.3% over the ten-quarter window with no compounding trend, while ROA has stayed depressed at 2.1-3.1% because asset turnover of 0.23, not margin, is the binding constraint on the return stack. Judged against a typical consumer-staples cost of capital in the 6-8% range, a ~5% ROIC suggests the company may be earning near or below its hurdle on incremental invested capital, which would challenge the assumption that the DSD network is currently generating economic profit rather than merely protecting share. Investors should note that ROIC here is computed on a consolidated asset base including goodwill of $18.9B, so the operating return on the tangible distribution platform alone is likely somewhat higher than the headline.

The moderation in D/E from its 2.77x peak in 2025Q2 to 2.31x appears to reflect equity recovery from a trough rather than meaningful debt retirement, since absolute debt continued to climb, which implies deleveraging has been optical rather than cash-funded. With approximately $21B of dividends paid against roughly $25B of cumulative free cash flow over the window, internal capacity for debt reduction is structurally limited, and a sustained payout at this level would appear to require either stable refinancing access or further balance-sheet expansion. The 1.77x coverage reading in 2026Q2, if it reflects a genuine earnings or interest-expense event rather than a data artifact, would mark a materially tighter debt-service posture than the 10-18x levels seen through 2024-2025, and the absence of a subsequent reading leaves this unresolved.

The payables period has extended from 149 days in 2025Q4 to 182 days in 2026Q3, improving the conversion cycle from -54 to -89 days; this appears to be a financing choice captured in the cash flow statement rather than a structural improvement in operating efficiency. Asset turnover of 0.23, moving seasonally between 0.18 and 0.28, confirms that the revenue base remains modest relative to a $112B asset footprint, consistent with a capital-heavy consolidated bottling and DSD model. Analysts should recognize the key sensitivity: a negative cycle of this magnitude is a source of float only while suppliers accept these terms, and any tightening, or a consumer-driven volume decline, would compress the operating cash inflows on which the sub-1.0 current ratio depends.